Skip to main content

Profiles

Coleman Rotstein

Coleman Rotstein is a Canadian infectious diseases specialist based in Toronto, Ontario. He is a professor of medicine at the University of Toronto, and an attending physician and director of oncologic infectious diseases at the University Health Network.[1][2] He is a faculty member for Mentoring in IBD, an annual education program for Canadian gastroenterologists.[3] He was formerly president of the Association of Medical Microbiology and Infectious Disease Canada (AMMI).[3:1]

He is notable in the COVID-19 pandemic due to his role in developing guidelines for use of COVID-19 vaccines in Canada as a part of the National Advisory Committee on Immunization (NACI).[4]

History

Rotstein received a Bachelor of Science at the University of Toronto and earned his medical degree from the University of Calgary in 1976. He completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston, South Carolina from 1980 to 1983.

Rotstein was a speaker at the 2021 Winter Hematology Update hosted by CARE Education, where he presented on the topic of COVID-19 vaccines in oncology patients.[5][6]

Activities

Rotstein has received grants from Astellas Pharma, Chimerix, Cidara Therapeutics, Merck, Pfizer, and other funding (including personal, consulting and speaking fees) from Avir Pharma, Merck, Pendopharm, Pfizer, Roche, Sunovion Pharmaceuticals, and Teva Pharmaceuticals.[7][8]

  1. Princess Margaret Cancer Centre Multiple Myeloma Day. University of Toronto. Retrieved April 18, 2022, from http://archive.vn/2022.04.19-050616/https://www.cpd.utoronto.ca/myeloma/faculty/ ↩︎

  2. Transplant Research Team. University Health Network. Retrieved April 19, 2022, from http://archive.vn/2022.04.19-154403/https://www.uhn.ca/Transplant/Research/Pages/Transplant_Research_Team.aspx ↩︎

  3. Rotstein, Coleman. Mentoring in IBD. Retrieved April 19, 2022, from http://archive.vn/2022.04.19-151643/https://www.mentoringinibd.com/faculty-member/rotstein-coleman/ ↩︎ ↩︎

  4. National Advisory Committee on Immunization (NACI): Membership and representation. (2020, December 18). Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html ↩︎

  5. Rotstein, C. (2021). COVID-19 Vaccines in Oncology Patients. CARE Education. https://web.archive.org/web/20220419144942/https://careeducation.ca/wp-content/uploads/2021/02/Dr.-Rotstein-WHU-Final-Presentation-.pdf ↩︎

  6. CARE Education. (2021, February 25). COVID-19 Vaccines in Oncology Patients - Dr. Coleman Rotstein (University Health Network). YouTube. https://www.youtube.com/watch?v=TCHWvKhxQ5o ↩︎

  7. Marinelli, T., & Rotstein, C. (2020). Invasive fungal infections (IFIs) in lung transplant recipients. Clinical Infectious Diseases, 74(3). https://doi.org/10.1093/cid/ciaa603 ↩︎

  8. Pérez-Cortés Villalobos, A., & Rotstein, C. (2021). Mycobacterium mucogenicum and Mycobacterium neoaurum bacteremia in immunocompromised hosts. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada, 6(1), 55–62. https://doi.org/10.3138/jammi-2020-0025 ↩︎